Juana Cuevas
Obstetrics & Gynecology · New York, NYNPI 1700076981
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,258 of the $1,468 with a category attached, or 85.7%. It is spread thinly across 21 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $413 and has fallen 75.0% since, to $103 in 2025.
Across 58 payments — averaging $25.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$263
- Hologic Sales And Service, LLC$242
- Sumitomo Pharma America, Inc.$168
- Lupin Inc.$137
- Avanos Medical$125
- Coopersurgical, Inc.$87
- plus $446 from 15 others
Across 1 payment — averaging $10,088 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Myovant Sciences Inc.$10K
What the payments were for
- Food & beverage$1,25886%
- Education$21014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 6 | $263 |
| Hologic Sales And Service, LLC | 6 | $242 |
| Sumitomo Pharma America, Inc. | 2 | $168 |
| Lupin Inc. | 12 | $137 |
| Avanos Medical | 1 | $125 |
| Coopersurgical, Inc. | 4 | $87 |
| Mylan Pharmaceuticals Inc. | 4 | $80 |
| Evofem Biosciences, Inc. | 3 | $63 |
| AbbVie | 2 | $43 |
| Myovant Sciences Inc. | 2 | $34 |
| Avion Pharmaceuticals | 2 | $30 |
| Agile Therapeutics, Inc. | 2 | $29 |
| Mayne Pharma Commercial LLC | 2 | $26 |
| Bayer | 1 | $19 |
| Organon | 3 | $19 |
| Aspira Women's Health Inc | 1 | $18 |
| Merck | 1 | $18 |
| Olympus America Inc. | 1 | $18 |
| Biogen | 1 | $18 |
| Renovia Inc | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,468 in reported general payments places this provider in the 75th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 69 | $3,141 |
| Clobetasol Propionate | 18 | $1,081 |
| ValacyclovirValacyclovir Hcl | 52 | $636 |
| Nystatin | 15 | $167 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $136 |
| Fluconazole | 20 | $103 |
| Triamcinolone Acetonide | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New York
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
- Melanie MarinNew York$123K
- Amitasrigowri MurthyNew York$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.